The best perinatal depression screening: Is self-administered PHQ2 more feasible than a nurse-administered one?

Sarah Reinstein; Kate Lieb; Peter S. Bernstein; Chavi Eve Karkowsky

doi:10.1111/ppc.12383

The best perinatal depression screening: Is self-administered PHQ2 more feasible than a nurse-administered one?

Sarah Reinstein, Kate Lieb, Peter S. Bernstein, Chavi Eve Karkowsky

Obstetrics & Gynecology and Women's Health

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Purpose: To assess perinatal depression screening via self-administered PHQ2 (SAP) vs nurse-administered PHQ2 (NAP). Design and Methods: NAP screening was performed for 3 months, followed by SAP. Data were gathered from visits at 24 to 28 weeks gestation. Findings: One hundred twenty-seven patients were in NAP arm, 100 in SAP arm. SAP had higher rates of screening (odds ratio [OR], 3.25; 95% confidence interval [CI], 1.63-6.49), but no difference in positive PHQ2 screens. The SAP rate of therapeutic action for positive screens was lower (OR, 0.24; 95% CI, 0.12-0.50). Practice Implications: SAP provided higher perinatal depression screening rates compared to NAP, but decreased therapeutic action.

Original language	English (US)
Pages (from-to)	81-85
Number of pages	5
Journal	Perspectives in Psychiatric Care
Volume	56
Issue number	1
DOIs	https://doi.org/10.1111/ppc.12383
State	Published - Jan 1 2020

Keywords

depression
postpartum period
pregnancy
screening method

ASJC Scopus subject areas

Phychiatric Mental Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ppc.12383

Cite this

@article{cdb60b5adf714962887c1b26dce0758f,

title = "The best perinatal depression screening: Is self-administered PHQ2 more feasible than a nurse-administered one?",

abstract = "Purpose: To assess perinatal depression screening via self-administered PHQ2 (SAP) vs nurse-administered PHQ2 (NAP). Design and Methods: NAP screening was performed for 3 months, followed by SAP. Data were gathered from visits at 24 to 28 weeks gestation. Findings: One hundred twenty-seven patients were in NAP arm, 100 in SAP arm. SAP had higher rates of screening (odds ratio [OR], 3.25; 95% confidence interval [CI], 1.63-6.49), but no difference in positive PHQ2 screens. The SAP rate of therapeutic action for positive screens was lower (OR, 0.24; 95% CI, 0.12-0.50). Practice Implications: SAP provided higher perinatal depression screening rates compared to NAP, but decreased therapeutic action.",

keywords = "depression, postpartum period, pregnancy, screening method",

author = "Sarah Reinstein and Kate Lieb and Bernstein, {Peter S.} and Karkowsky, {Chavi Eve}",

note = "Publisher Copyright: {\textcopyright} 2019 Wiley Periodicals, Inc.",

year = "2020",

month = jan,

day = "1",

doi = "10.1111/ppc.12383",

language = "English (US)",

volume = "56",

pages = "81--85",

journal = "Perspectives in Psychiatric Care",

issn = "0031-5990",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - The best perinatal depression screening

T2 - Is self-administered PHQ2 more feasible than a nurse-administered one?

AU - Reinstein, Sarah

AU - Lieb, Kate

AU - Bernstein, Peter S.

AU - Karkowsky, Chavi Eve

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Purpose: To assess perinatal depression screening via self-administered PHQ2 (SAP) vs nurse-administered PHQ2 (NAP). Design and Methods: NAP screening was performed for 3 months, followed by SAP. Data were gathered from visits at 24 to 28 weeks gestation. Findings: One hundred twenty-seven patients were in NAP arm, 100 in SAP arm. SAP had higher rates of screening (odds ratio [OR], 3.25; 95% confidence interval [CI], 1.63-6.49), but no difference in positive PHQ2 screens. The SAP rate of therapeutic action for positive screens was lower (OR, 0.24; 95% CI, 0.12-0.50). Practice Implications: SAP provided higher perinatal depression screening rates compared to NAP, but decreased therapeutic action.

AB - Purpose: To assess perinatal depression screening via self-administered PHQ2 (SAP) vs nurse-administered PHQ2 (NAP). Design and Methods: NAP screening was performed for 3 months, followed by SAP. Data were gathered from visits at 24 to 28 weeks gestation. Findings: One hundred twenty-seven patients were in NAP arm, 100 in SAP arm. SAP had higher rates of screening (odds ratio [OR], 3.25; 95% confidence interval [CI], 1.63-6.49), but no difference in positive PHQ2 screens. The SAP rate of therapeutic action for positive screens was lower (OR, 0.24; 95% CI, 0.12-0.50). Practice Implications: SAP provided higher perinatal depression screening rates compared to NAP, but decreased therapeutic action.

KW - depression

KW - postpartum period

KW - pregnancy

KW - screening method

UR - http://www.scopus.com/inward/record.url?scp=85077214629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077214629&partnerID=8YFLogxK

U2 - 10.1111/ppc.12383

DO - 10.1111/ppc.12383

M3 - Article

C2 - 31001837

AN - SCOPUS:85077214629

SN - 0031-5990

VL - 56

SP - 81

EP - 85

JO - Perspectives in Psychiatric Care

JF - Perspectives in Psychiatric Care

IS - 1

ER -

The best perinatal depression screening: Is self-administered PHQ2 more feasible than a nurse-administered one?

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this